Experimental Pathology Laboratories, Inc. (EPL) and Aclairo Pharmaceutical Development Group, Inc. (Aclairo) are excited to announce that Dr. Heath Thomas has joined Aclairo as President and Senior Consultant.
Dr. Thomas is a board-certified veterinary pathologist with over 20 years of experience in drug development from time spent with SmithKline Beecham, DuPont Pharmaceuticals, and GlaxoSmithKline, as well as several years of consulting experience with EPL. He served as VP of Safety Assessment and Head of Pathology for many years at a large pharmaceutical company covering multiple different therapeutic areas. He has directed or consulted on numerous drug development projects from early discovery through filing, along with due diligence exercises.
In addition to his leadership and consultation roles, Dr. Thomas will also continue to be involved with pathology peer review, pathology working group (PWG), and scientific advisory panel services.
With Dr. Thomas now in place as the new Aclairo President, and the succession process completed, Dr. Susan Wilson has transitioned into the role of Senior Advisor at Aclairo. In her role as Senior Advisor, Dr. Wilson will continue to provide scientific and regulatory advice and expertise.
We congratulate both Heath and Susan on their new roles!